問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
林泰祺
下載
2020-09-01 - 2024-09-18
Condition/Disease
Test Drug
Participate Sites3Sites
Recruiting3Sites
2020-12-01 - 2024-06-30
Diabetic Macular Edema
FARICIMAB (RO6867461)
2024-01-31 - 2027-12-31
2021-11-01 - 2031-12-31
Participate Sites5Sites
Recruiting5Sites
2021-07-01 - 2027-12-31
2023-01-01 - 2026-12-31
2022-08-01 - 2027-06-30
Participate Sites2Sites
Recruiting2Sites
2022-05-01 - 2024-08-16
2023-07-03 - 2026-12-31
Participate Sites4Sites
Recruiting4Sites
2022-07-01 - 2028-12-31
全部
